This is a summary, images and full post available on HHL website!
* This article was originally published here
Steve Inskeep talks to Nick Florko of the news site Stat, which covers health and medicine, about the White House requiring drugmakers to display the cost of drugs when they advertise on TV.
The latest edition of #CareTalk is out. CareCentrix CEO, John Driscoll and I explore the departure of FDA Director Scott Gottlieb and other pressing topics.
Here’s what we covered:
(0:28) Scott Gottlieb is out at FDA. Are you sad to see him go?
(2:00) Home health spending is projected to grow faster than any other category of healthcare over the coming years. Is that good or bad?
(4:00) Insulin prices are spiking and both Democrats and Republicans are up in arms. What’s happening?
(5:53) Lyft is talking about the social determinants of health. What?!
(8:47) What do you think about FDA approving ketamine nasal spray as a treatment for depression?
(9:10) What did we learn about healthcare from Michael Cohen’s Congressional testimony?
(9:33) Medicare has a new app. Have you tried it?
(9:59) Did you hear about the $48,500 bill for a cat bite?
Subscribe to the #CareTalk Podcast
iTunes: https://apple.co/2DIDTcr
Google Play: https://bit.ly/2RobqMB
The post #CareTalk March 2019: Gottlieb’s out. What’s next for FDA? appeared first on Health Business Group.
A dengue vaccine put thousands of kids at risk for a deadly disorder. Some scientists says the manufacturer did too little to warn parents in the Philippines.

Steve Wiggins has seen a thing or two in his more than three decades as a healthcare entrepreneur. His Oxford Health Plans introduced “pods,” a precursor of the Accountable Care Organization and he led HealthMarket, an early player in the consumer directed health plan space. He’s carried the same themes into his current role as founder and Chairman of Remedy Partners, the leader in Medicare’s Bundled Payments for Care Initiative (BPCI).
As you’ll hear in this podcast, Steve’s a big believer in bundles, offering them as a proven solution for a large portion of the healthcare dollar, within almost any healthcare financing framework from traditional commercial coverage to Medicare for All.
Here’s what we discussed:
—
By healthcare business consultant David E. Williams, president of Health Business Group.
The post Remedy Partners founder Steve Wiggins explains why he’s high on bundled payments (podcast) appeared first on Health Business Group.